Hepatitis Panel/Acute Hepatitis Panel

The Hepatitis Panel (HAAb IgM, HBcAb IgM, HBsAg, and HCV antibody) is covered to detect viral hepatitis in patients with abnormal liver function tests, for differential diagnosis of liver disease, and for pre- and post-liver transplantation evaluation. After hepatitis is diagnosed, coverage is limited to individual hepatitis tests rather than repeating the full panel; repeat panel testing is allowed 2 weeks to 2 months after a negative panel if exposure timing is uncertain and symptoms persist, and HBsAb may be checked monthly up to six months post-vaccination to verify response.

"Covered to detect viral hepatitis infection in patients with abnormal liver function test (LFT) results, with or without signs or symptoms of hepatitis."

Sign up to see full coverage criteria, indications, and limitations.